BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1680275)

  • 21. Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.
    Moree WJ; Li BF; Jovic F; Coon T; Yu J; Gross RS; Tucci F; Marinkovic D; Zamani-Kord S; Malany S; Bradbury MJ; Hernandez LM; O'Brien Z; Wen J; Wang H; Hoare SR; Petroski RE; Sacaan A; Madan A; Crowe PD; Beaton G
    J Med Chem; 2009 Sep; 52(17):5307-10. PubMed ID: 19663387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimentally induced pruritus and cutaneous reactions with topical antihistamine and local analgesics in atopic eczema.
    Weisshaar E; Forster C; Dotzer M; Heyer G
    Skin Pharmacol; 1997; 10(4):183-90. PubMed ID: 9413892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
    Deschamps C; Dubruc C; Mentre F; Rosenzweig P
    Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acrivastine--an evaluation of initial and peak activity in human skin.
    Marks P; Manna VK; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new antihistamine hc20-511 compared with dimetinden (fenistil retard) in the treatment of chronic urticaria and other pruritic dermatoses.
    Kuokkanen K
    Acta Allergol; 1975 Jul; 30(2-3):73-9. PubMed ID: 239517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
    Wang RQ; Zhang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and tolerance to mebhydroline in comparison with dimetindene maleate].
    Guzzetti R; Saggiorato F
    Clin Ter; 1986 Jan; 116(2):109-14. PubMed ID: 2870838
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prescription and safety of dimethindene maleate micropellet capsules in Hungary].
    Mikó P
    Orv Hetil; 2004 Feb; 145(7):327-9. PubMed ID: 15049047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of effects of 5 and 10 mg oral desloratadine and levocetirizine on histamine-induced wheal and flare response in healthy volunteers.
    Bulca S; Bayramgürler D; Odyakmaz Demirsoy E; Yavuz M; Sikar Aktürk A; Bilen N; Kıran R
    J Dermatolog Treat; 2013 Dec; 24(6):473-6. PubMed ID: 23441762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of antihistaminic activity of cetirizine by nimesulide.
    Rewari S; Gupta U
    J Assoc Physicians India; 1999 Apr; 47(4):389-92. PubMed ID: 10778521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
    Kruszewski J; Kłos K; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anaphylactoid reactions following administration of plasma substitutes in man. Prevention of this side-effect of haemaccel by premedication with H1- and H2-receptor antagonists (author's transl)].
    Lorenz W; Doenicke A; Dittmann I; Hug P; Schwarz B
    Anaesthesist; 1977 Dec; 26(12):644-8. PubMed ID: 23706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dimethindene maleate on psychomotor performance in the oculodynamic test compared with placebo and loratadine.
    Englisch W; Rehn D; Schaffler K; Wauschkuhn CH
    Arzneimittelforschung; 1996 Sep; 46(9):887-90. PubMed ID: 8876938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variations of skin sensitivity to intracutaneous histamine provocations with regard to provocation time.
    Rehn D; Geissler H; Schönbrunn U; Lukas H; Rahlfs VW; Hennings G
    Arzneimittelforschung; 1990 Jul; 40(7):777-81. PubMed ID: 2222553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A long-acting antihistamine.
    Practitioner; 1966 Jul; 197(177):96-9. PubMed ID: 4380327
    [No Abstract]   [Full Text] [Related]  

  • 38. Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene.
    Nicholson AN; Pascoe PA; Turner C; Ganellin CR; Greengrass PM; Casy AF; Mercer AD
    Br J Pharmacol; 1991 Sep; 104(1):270-6. PubMed ID: 1686208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?
    Devillier P; Bousquet J
    Clin Exp Allergy; 2007 Mar; 37(3):400-14. PubMed ID: 17359390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction.
    Purohit A; N'Gom AS; Deslandes B; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):562-7. PubMed ID: 15609766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.